Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer
Open Access
- 5 January 2022
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 44 (1) , 233-241
Abstract
According to a report from the World Health Organization (WHO), the mortality and disease severity induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are significantly higher in cancer patients than those of individuals with no known condition. Common and cancer-specific risk factors might be involved in the mortality and severity rates observed in the coronavirus disease 2019 (COVID-19). Similarly, various factors might contribute to the aggravation of COVID-19 in patients with cancer. However, the factors involved in the aggravation of COVID-19 in cancer patients have not been fully investigated so far. The formation of metastases in other organs is common in cancer patients. Therefore, the present study investigated the association between lung metastatic lesion formation and SARS-CoV-2 infectivity. In the pulmonary micrometastatic niche of patients with ovarian cancer, alveolar epithelial stem-like cells were found adjacent to ovarian cancer. Moreover, angiotensin-converting enzyme 2, a host-side receptor for SARS-CoV-2, was expressed in these alveolar epithelial stem-like cells. Furthermore, the spike glycoprotein receptor-binding domain (RBD) of SARS-CoV-2 was bound to alveolar epithelial stem-like cells. Altogether, these data suggested that patients with cancer and pulmonary micrometastases are more susceptible to SARS-CoV-2. The prevention of de novo niche formation in metastatic diseases might constitute a new strategy for the clinical treatment of COVID-19 for patients with cancer.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (19K09840)
- Japan Science and Technology Agency (STSC20001)
This publication has 15 references indexed in Scilit:
- Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patientCell Research, 2020
- Characteristics of Leiomyosarcoma: Induction of Hematogenous Metastasis by Isolated Uterine Mesenchymal Tumor Stem-like CellsAnticancer Research, 2020
- Initialization of epithelial cells by tumor cells in a metastatic microenvironmentOncogene, 2020
- Cells tagged near an early spread of cancerNature, 2019
- Metastatic-niche labelling reveals parenchymal cells with stem featuresNature, 2019
- Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancerMolecular Oncology, 2019
- New serum tumor markers S100, TFF3 and AIF-1 and their possible use in oncogynecology2019
- Guidelines on Vaccinations in Paediatric Haematology and Oncology PatientsBioMed Research International, 2014
- Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF‐1α to a hypoxia‐induced, methylation‐free hypoxia response element of S100A4 geneInternational Journal of Cancer, 2012
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowJournal of Clinical Investigation, 2011